tiprankstipranks
Advertisement
Advertisement

SCYX Stock Latest News

SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
Company AnnouncementsSCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
8d ago
8K
SCYX
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
PremiumCompany Announcements
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
8d ago
8K
SCYX
SCYNEXIS Raises $40 Million in Strategic Private Placement
PremiumCompany Announcements
SCYNEXIS Raises $40 Million in Strategic Private Placement
8d ago
8K
SCYX
Poxel announces sale of PXL770 to Scynexis for up to $196M
PremiumThe Fly
Poxel announces sale of PXL770 to Scynexis for up to $196M
8d ago
SCYX
Scynexis completes acquisition of PXL-770 for treatment of kidney disease
PremiumThe Fly
Scynexis completes acquisition of PXL-770 for treatment of kidney disease
8d ago
SCYX
Scynexis announces $40M private placement
PremiumThe FlyScynexis announces $40M private placement
8d ago
SCYX
Buy Rating on Scynexis Backed by Strong Cash Runway and Differentiated Next‑Generation Antifungal SCY‑247 Opportunity
Premium
Ratings
Buy Rating on Scynexis Backed by Strong Cash Runway and Differentiated Next‑Generation Antifungal SCY‑247 Opportunity
20d ago
SCYX
Scynexis announces first patients dosed in Phase 1 SAD, MAD trial of SCY-247
Premium
The Fly
Scynexis announces first patients dosed in Phase 1 SAD, MAD trial of SCY-247
1M ago
SCYX
Cero Therapeutics appoints Eric Francois to board of directors
PremiumThe Fly
Cero Therapeutics appoints Eric Francois to board of directors
2M ago
CERO
SCYX
Scynexis announces presentation highlighting data from SCY-247
PremiumThe Fly
Scynexis announces presentation highlighting data from SCY-247
2M ago
SCYX
Scynexis receives U.S. FDA QIDP, Fast Track Designations for SCY-247
PremiumThe Fly
Scynexis receives U.S. FDA QIDP, Fast Track Designations for SCY-247
3M ago
SCYX
Scynexis granted 180-day extension by Nasdaq to regain compliance
PremiumThe Fly
Scynexis granted 180-day extension by Nasdaq to regain compliance
4M ago
SCYX
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
PremiumCompany AnnouncementsSCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
4M ago
SCYX
Scynexis completes transfer of BREXAFEMME NDA to GSK
Premium
The Fly
Scynexis completes transfer of BREXAFEMME NDA to GSK
5M ago
GSK
SCYX
Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration
Premium
The Fly
Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration
5M ago
SCYX
SCYNEXIS: Strong Financial Position and Promising Antifungal Pipeline Drive Buy Rating
PremiumRatings
SCYNEXIS: Strong Financial Position and Promising Antifungal Pipeline Drive Buy Rating
5M ago
SCYX
SCYNEXIS Reports Q3 2025 Financial Results and Strategic Updates
PremiumCompany Announcements
SCYNEXIS Reports Q3 2025 Financial Results and Strategic Updates
5M ago
SCYX
Scynexis reports Q3 EPS (17c), consensus (20c)
PremiumThe Fly
Scynexis reports Q3 EPS (17c), consensus (20c)
5M ago
SCYX
SCYX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
SCYX Upcoming Earnings Report: What to Expect?
5M ago
SCYX
Scynexis price target lowered to $3 from $4 at Guggenheim
PremiumThe FlyScynexis price target lowered to $3 from $4 at Guggenheim
5M ago
GSK
SCYX
SCYNEXIS: Strategic Advancements and Financial Stability Drive Buy Rating
Premium
Ratings
SCYNEXIS: Strategic Advancements and Financial Stability Drive Buy Rating
6M ago
SCYX
SCYNEXIS and GSK Amend License Agreement
Premium
Company Announcements
SCYNEXIS and GSK Amend License Agreement
6M ago
8K
SCYX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >